Idarubicin Injection 5 mg/5 mL (4)

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

idarubicin hydrochloride, Quantity: 1 mg/mL

Tilgængelig fra:

Pfizer (Perth) Pty Ltd

Lægemiddelform:

Injection, solution

Sammensætning:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Indgivelsesvej:

Intravenous Infusion, Intravenous

Enheder i pakken:

1 X 5 mL

Recept type:

(S1) This Schedule is intentionally blank

Terapeutiske indikationer:

TAIWAN Acute non-lymphatic leukaemia (ANLL) in adults. Acute lymphatic leukaemia (ALL) in adults and children

Produkt oversigt:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisation status:

Listed (Export Only)

Autorisation dato:

2023-03-20